Post by
MustangSalley on Feb 16, 2022 11:50pm
Vertex mentioned as takeover target
Mentions successful diabetes progress by Vertex. Sva in comparison is years away before any buyout imo. https://www.fiercebiotech.com/special-report/top-10-m-a-targets-biotech-for-2022 Ms Sally
Comment by
BioTeck on Feb 17, 2022 1:15am
Vertex should just buy sernova. Use their own cells and use sernovas pouch. Unless sernova teams up with someone with better cells, it makes sense.